Quick10K

⚲

IMAX

Filings

10-Q	2021-03-31	Filed 2021-04-29
10-K	2020-12-31	Filed 2021-03-04
10-Q	2020-09-30	Filed 2020-10-29
10-Q	2020-06-30	Filed 2020-07-28
10-Q	2020-03-31	Filed 2020-04-30
10-K	2019-12-31	Filed 2020-02-19
10-Q	2019-09-30	Filed 2019-10-31
10-Q	2019-06-30	Filed 2019-07-30
10-Q	2019-03-31	Filed 2019-04-26
10-K	2018-12-31	Filed 2019-02-26
10-Q	2018-09-30	Filed 2018-10-25
10-Q	2018-06-30	Filed 2018-07-25
10-Q	2018-03-31	Filed 2018-05-01
10-K	2017-12-31	Filed 2018-02-27
10-Q	2017-09-30	Filed 2017-10-26
10-Q	2017-06-30	Filed 2017-07-26
10-Q	2017-03-31	Filed 2017-04-20
10-K	2016-12-31	Filed 2017-02-23
10-Q	2016-09-30	Filed 2016-10-20
10-Q	2016-06-30	Filed 2016-07-20
10-Q	2016-03-31	Filed 2016-04-21
10-K	2015-12-31	Filed 2016-02-24
10-Q	2015-09-30	Filed 2015-10-28
10-Q	2015-06-30	Filed 2015-07-23
10-Q	2015-03-31	Filed 2015-04-30
10-K	2014-12-31	Filed 2015-02-19
10-Q	2014-09-30	Filed 2014-10-23
10-Q	2014-06-30	Filed 2014-07-24
10-Q	2014-03-31	Filed 2014-04-24
10-K	2013-12-31	Filed 2014-02-20
10-Q	2013-09-30	Filed 2013-10-24
10-Q	2013-06-30	Filed 2013-07-25
10-Q	2013-03-31	Filed 2013-04-25
10-K	2012-12-31	Filed 2013-02-21
10-Q	2012-06-30	Filed 2012-07-26
10-Q	2012-03-31	Filed 2012-04-27
10-K	2011-12-31	Filed 2012-02-24
10-Q	2011-09-30	Filed 2011-10-27
10-Q	2011-06-30	Filed 2011-07-28
10-Q	2011-03-31	Filed 2011-04-28
10-K	2010-12-31	Filed 2011-02-24
10-Q	2010-09-30	Filed 2010-10-28
10-Q	2010-06-30	Filed 2010-07-29
10-Q	2010-03-31	Filed 2010-04-29
10-K	2009-12-31	Filed 2010-03-11

Reports

8-K	2020-10-29
8-K	2020-09-18
8-K	2020-07-28
8-K	2020-06-26
8-K	2020-06-10
8-K	2020-06-03
8-K	2020-04-30
8-K	2020-03-11
8-K	2020-02-19
8-K	2019-12-17
8-K	2019-11-20
8-K	2019-10-31
8-K	2019-10-30
8-K	2019-07-30
8-K	2019-06-05
8-K	2019-04-26
8-K	2019-02-26
8-K	2018-12-13
8-K	2018-10-25
8-K	2018-10-15
8-K	2018-07-25
8-K	2018-06-28
8-K	2018-06-05
8-K	2018-05-01
8-K	2018-03-23
8-K	2018-02-27

IMAX Financials

IMAX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	17	23	19	18	22	24	29	21	15	21	26	30	30	75	94	107	140	146	117	317	260	228	218	205	190	158	158	159	146	133	134	142	123	106	103
Accounts Receivable	31	44	40	47	46	47	36	42	48	63	44	73	60	73	60	76	66	91	88	98	92	95	89	96	96	96	103	131	120	113	106	93	94	91	82
Inventory		18	22	20	21	20	21	16	14	13	14	10	14	17	21	17	26	34	36	39	45	45	51	42	45	41	37	31	29	41	53	45	45	48	58
PP&E	78	171	180	189	195	193	190	195	206	211	220	225	239	252	267	290	305	315	326	328	336	356	362	378	388	403	421	428	439	442	276	452	302	308	305
Assets	337	372	374	406	414	425	427	422	432	454	447	481	478	538	561	622	676	727	714	931	879	867	859	857	841	840	847	867	878	870	874	874	893	876	870
Accounts Payable
Long-Term Debt				55				11												30	29	28	28	28	27	26	26	26	25	25	18	38	58	23	18
Liabilities	175	201	193	213	212	206	188	169	172	177	163	162	155	157	173	195	198	208	219	254	228	240	232	231	217	258	255	263	245	257	252	274	286	265	251
Stockholders' Equity	162	171	181	193	202	219	239	253	260	277	284	320	323	344	350	383	394	433	407	624	596	569	568	562	561	515	520	528	549	527	537	512	516	519	527


Income Statement ($MM)	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	45	57	67	67	56	70	81	78	50	82	52	104	48	79	61	102	62	107	85	119	92	92	87	107	69	88	99	126	85	98	82	109	80	105	86
Cost of Revenue	11	31	31	37	29	31	36	35	24	39	24	36	22	31	25	39	26	38	43	21	40	41	42	52	33	38	59	65	34	38	40	54	35	45	39
Gross Profit	21	26	36	30	27	39	45	42	26	44	27	68	26	48	35	64	36	69	42	72	52	50	45	55	36	49	40	60	51	60	42	55	45	60	47
R&D	2	2	2	2	3	3	3	4	4	5	4	4	4	3	5	5	5	2	3	3	4	3	4	5	4	6	5	6	4	4	4		1	1	1
SG&A																																		1	0
Tax	-0	2	5	1	1	4	7	0	1	5	1	10	3	5	1	8	14	9	2	8	12	3	3	7	7	6	4	18	5	3	-1		-4	5	3
Net Income	-1	2	8	6	3	11	15	13	3	12	2	28	1	14	5	21	1	26	11	22	12	11	4	12	0	2	3	9	12	17	8	4	12	14	11


Cash Flow ($MM)	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	-10	-1	4	13	10	9	34	20	-1	9	25	22	14	21	37	15	6	12	23	42	5	31	9	33	-1	38	26	22	15	31	21		-1	49	19
Cash Investing	-4	-14	-14	-31	-10	-9	-4	-12	-13	-5	-9	-15	-14	-15	-17	-17	-28	-21	-16	-14	-9	-22	-8	-26	-14	-17	-26	-16	-12	-7	-14		-28	-15	-11
Cash Financing	1	21	6	18	3	2	-24	-16	8	1	-10	-3	-0	39	-1	15	56	15	-37	171	-53	-41	-12	-19	0	-53	-1	-4	-17	-37	-6		10	-51	-12